Cost-Effectiveness of the Manchester Approach to Identifying Lynch Syndrome in Women with Endometrial Cancer

Lynch syndrome (LS) is a hereditary cancer syndrome responsible for 3% of all endometrial cancer and 5% in those aged under 70 years. It is unclear whether universal testing for LS in endometrial cancer patients would be cost-effective. The Manchester approach to identifying LS in endometrial cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Snowsill, Tristan M., Ryan, Neil A. J., Crosbie, Emma J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356917/
https://www.ncbi.nlm.nih.gov/pubmed/32492863
http://dx.doi.org/10.3390/jcm9061664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356917/
https://www.ncbi.nlm.nih.gov/pubmed/32492863
http://dx.doi.org/10.3390/jcm9061664

Ejemplares similares